Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hadley Greenwood has a total of 35 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Mechanisms of Inflammation in Post-Operative Recurrence of Crohn’s Disease

    by Hadley Greenwood, Calen Steiner, Benjamin Click

    Despite advances in guideline-directed surveillance and initiation of biologic therapy after ileocecal resection for Crohn’s disease, many patients still experience post-operative recurrence. There is a growing field of research on the mechanisms of inflammation that are specific to post-operative recurrence after surgical resection and anastomosis. Within the innate immune system, certain genetic risk factors and an imbalance in matrix metalloproteinases have been implicated; however, the roles of specific innate immune cells are still being studied. Within the adaptive immune system, increased T-cell clonal expansion at the time of surgery and specific antibodies may play important roles in inflammation after resection. There are emerging associations to link mitochondrial oxidative stress, specific chemokines and cytokines, and microbial dysbiosis to the processes driving post-operative inflammation.

  • Open Access

    ANCA-Negative Granulomatous Polyangiitis Presenting With Isolated Oral and Esophageal Involvement

    by Hadley Greenwood, Jeffrey Kaplan, Benjamin Click

    Granulomatosis with polyangiitis (GPA) is a necrotizing small vessel vasculitis, which is most classically associated with lung and renal involvement. In this article, we present a young man who presented with oral ulcers, odynophagia, and foreign body sensation in the esophagus. Upper endoscopy revealed many esophageal ulcers with biopsies highly suspicious for GPA and no infectious etiologies identified on extensive testing. To our knowledge, this is a unique diagnosis of ANCA-negative GPA in a patient presenting with isolated oral and esophageal involvement.

  • S5017 The Cost of Control: A Case of Pneumocystis Pneumonia While on Upadacitinib for Crohn’s Disease

    by Paige E. Hammis, Hadley Greenwood, Anthony Robateau Colón, Mark Gerich, Waseem Ahmed

  • S5429 Cirrhosis Secondary to Hereditary Hemochromatosis in a Young Man With Williams Syndrome

    by Hadley Greenwood, Paige E. Hammis, Anthony Robateau Colón, J. P. Norvell

  • Delayed diagnosis in adolescent onset focal epilepsy: Impact on morbidity and mental health

    by Monica Ferrer, Nora Jandhyala, Jacob Pellinen, Hadley Greenwood, Liu Lin Thio, Dennis Dlugos, Kristen L. Park, Andres M. Kanner, Jacqueline French, Human Epilepsy Project Investigators

    Objective: This study was undertaken to investigate diagnostic delay in adolescent onset focal epilepsy, including reasons for longer delays and associated morbidities.Methods: Secondary analysis was done using enrollment data from the Human Epilepsy Project, a multi‐institutional cohort including 34 sites in the USA, Canada, Finland, Austria, and Australia (2012–2017). Participants were aged 11–64 years at enrollment and within 4 months of treatment initiation for newly diagnosed focal epilepsy. Participants with seizure onset at age ≤ 21 years were evaluated. Data included seizure diaries documenting onset, frequency, and characteristics of seizures, reasons for diagnostic delays, and prediagnosis morbidities, including injuries, suicidal ideation, and self‐injurious behaviors.Results: Of 152 participants with adolescent onset seizures, those with a diagnosis delay > 1 year experienced a median delay to diagnosis of 4.4 years and reported higher rates of initial nonmotor seizures compared to those diagnosed within 1 year (n = 55, 78.6% vs. n = 33, 40.2%; χ21 = 22.76, p < .001). Lack of recognition by patients and health care providers accounted for diagnostic delay in more than half (68.2%) of participants with initial nonmotor seizures. Notably, 70% of participants with initial nonmotor seizures went undiagnosed until development of motor seizures. This group reported more injuries compared to those who did not develop motor seizures (56.5% vs. 7.7%; χ22 = 19.82, p < .001). Those with time to diagnosis > 1 year had more prediagnostic seizures (67 vs. 5.5 seizures, 95% confidence interval = 16.0–94.0; p < .001) and higher rates of suicidal ideation (33.3% vs. 14.9%; χ21 = 6.27, p = .01), suicidal behaviors (13.8% vs. 1.5%; χ21 = 7.19, p = .007), and nonsuicidal self‐injurious behaviors (13.4% vs. 1.5%; χ21 = 7.04, p = .008).Significance: This study highlights significant delays in diagnosing adolescent onset focal epilepsy, especially in cases with nonmotor seizures. These delays, often due to lack of recognition by patients and health care providers, are linked to more frequent seizures, higher injury rates, and increased suicidal ideation and self‐injury. Early recognition and diagnosis may mitigate adverse outcomes and improve quality of life for adolescents with epilepsy.


  • Prevalence of Suicidality in Adolescents With Newly Diagnosed Focal Epilepsy at Diagnosis and Over the Following 36 Months

    by Hadley T. Greenwood, Jacqueline French, Monica Ferrer, Nora Jandhyala, Liu Lin Thio, Dennis J. Dlugos, Kristen L. Park, Andres M. Kanner, for the Human Epilepsy Project Investigators

    Individuals with epilepsy have increased risk of suicidal ideation (SI) and behaviors when compared with the general population. This relationship has remained largely unexplored in adolescents. We investigated the prevalence of suicidality in adolescents with newly diagnosed focal epilepsy within 4 months of treatment initiation and over the following 36 months. This was a post hoc analysis of the enrollment and follow-up data from the Human Epilepsy Project, an international, multi-institutional study that enrolled participants between 2012 and 2017. Participants enrolled were 11-17 years of age within 4 months of treatment initiation for focal epilepsy. We used data from the Columbia Suicide Severity Rating Scale (C-SSRS), administered at enrollment and over the 36-month follow-up period, along with data from medical records. A total of 66 adolescent participants were enrolled and completed the C-SSRS. At enrollment, 14 (21%) had any lifetime SI and 5 (8%) had any lifetime suicidal behaviors (SBs). Over the following 36 months, 6 adolescents reported new onset SI and 5 adolescents reported new onset SB. Thus, the lifetime prevalence of SI within this population increased from 21% to 30% (14-20 adolescents), and the lifetime prevalence of SB increased from 8% to 15% (5-10). The prevalence of suicidality in adolescents with newly diagnosed focal epilepsy reported in our study is consistent with previous findings of significant suicidality observed in epilepsy. We identify adolescents as an at-risk population at the time of epilepsy diagnosis and in the following years.


  • Unrecognized Focal Nonmotor Seizures in Adolescents Presenting to Emergency Departments

    by Nora Jandhyala, Monica Ferrer, Jacob Pellinen, Hadley T. Greenwood, Dennis J. Dlugos, Kristen L. Park, Liu Lin Thio, Jacqueline French, for Human Epilepsy Project Investigators

    Many adolescents with undiagnosed focal epilepsy seek evaluation in emergency departments (EDs). Accurate history-taking is essential to prompt diagnosis and treatment. In this study, we investigated ED recognition of motor vs nonmotor seizures and its effect on management and treatment of focal epilepsy in adolescents. This was a retrospective analysis of enrollment data from the Human Epilepsy Project (HEP), an international multi-institutional study that collected data from 34 sites between 2012 and 2017. Participants were 12 years or older, neurotypical, and within 4 months of treatment initiation for focal epilepsy. We used HEP enrollment medical records to review participants' initial diagnosis and management. A total of 83 adolescents were enrolled between 12 and 18 years. Fifty-eight (70%) presented to an ED before diagnosis of epilepsy. Although most ED presentations were for motor seizures (n = 52; 90%), many patients had a history of nonmotor seizures (20/52 or 38%). Adolescents with initial nonmotor seizures were less likely to present to EDs (26/44 or 59% vs 32/39 or 82%, p = 0.02), and nonmotor seizures were less likely to be correctly identified (2/6 or 33% vs 42/52 or 81%, p = 0.008). A history of initial nonmotor seizures was not recognized in any adolescent who presented for a first-lifetime motor seizure. As a result, initiation of treatment and admission from the ED was not more likely for these adolescents who met the definition of epilepsy compared with those with no seizure history. This lack of nonmotor seizure history recognition in the ED was greater than that observed in the adult group (0% vs 23%, p = 0.03) and occurred in both pediatric and nonpediatric ED settings. Our study supports growing evidence that nonmotor seizures are often undiagnosed, with many individuals coming to attention only after conversion to motor seizures. We found this treatment gap is exacerbated in the adolescent population. Our study highlights a critical need for physicians to inquire about the symptoms of nonmotor seizures, even when the presenting seizure is motor. Future interventions should focus on improving nonmotor seizure recognition for this population in EDs.